Characteristics and long-term mortality of individuals with MASLD, MetALD, and ALD, and the utility of SAFE score

Pimsiri Sripongpun(Prince of Songkla University), W. Ray Kim(Mayo Clinic in Arizona), Apichat Kaewdech(Prince of Songkla University), Prowpanga Udompap(University of Minnesota)

JHEP Reports

June 3, 2024

10.1016/j.jhepr.2024.101127

Cited by 38

Related Papers

Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List

|New England Journal of Medicine|2008|1.5k

Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease†

|Hepatology|2008|865

Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites

|Journal of Hepatology|2015|864

Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases

|Hepatology|2021|794

Evidence-Based Incorporation of Serum Sodium Concentration Into MELD

|Gastroenterology|2006|777